Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,577Revenue (TTM) $M7,551Net Margin (%)9.4Altman Z-Score3.8
Enterprise Value $M17,974EPS (TTM) $5.0Operating Margin %17.2Piotroski F-Score8
P/E(ttm)21.5Beneish M-Score-2.6Pre-tax Margin (%)15.4Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %5.3Quick Ratio1.5Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %5.2Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow18.3y-y EBITDA Growth Rate %-5.7ROA % (ttm)7.0Higher Current Ratio y-yY
Dividend Yield %1.6PEG4.1ROE % (ttm)15.2Less Shares Outstanding y-yY
Payout Ratio %34.0Shares Outstanding M137ROIC % (ttm)9.9Gross Margin Increase y-yY

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

DGX is held by these investors:



DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRITELL JENNE KDirector 2017-04-24Sell6,111$104.032.41view
PREVOZNIK MICHAEL ESVP & General Counsel 2017-04-20Sell29,513$1006.54view
PREVOZNIK MICHAEL ESVP & General Counsel 2017-03-16Sell13,987$1006.54view
PREVOZNIK MICHAEL ESVP & General Counsel 2017-03-03Sell4,478$98.298.39view
Doherty Catherine T.SVP, Group Exec. Clin. Fran. 2017-03-03Sell7,162$98.288.4view
PREVOZNIK MICHAEL ESVP & General Counsel 2017-03-01Sell470$97.778.97view
PREVOZNIK MICHAEL ESVP & General Counsel 2017-02-27Sell440$97.399.4view
ZIEGLER JOHN BDirector 2017-02-22Sell2,000$95.5111.55view
Doherty Catherine T.SVP, Clin. Franchise Solutions 2017-02-15Sell1,615$94.6512.56view
PREVOZNIK MICHAEL ESVP & General Counsel 2017-02-13Sell1,200$93.7613.63view

Press Releases about DGX :

Quarterly/Annual Reports about DGX:

News about DGX:

Articles On GuruFocus.com
Quest Diagnostics Declares Quarterly Cash Dividend May 16 2017 
Increases in Illicit Drugs, Including Cocaine, Drive Workforce Drug Positivity to Highest Rate in 12 May 16 2017 
Quest Diagnostics To Speak At The UBS Global Healthcare Conference May 12 2017 
Quest Diagnostics To Speak At The Deutsche Bank 42nd Annual Health Care Conference May 02 2017 
Quest Diagnostics and PeaceHealth Complete Transaction to Increase Access to Innovative, High-value May 01 2017 
Quest Diagnostics CIO Lidia Fonseca Wins 2017 Forbes CIO Innovation Award May 01 2017 
Data Diagnostics Wins Gold at the 30th Annual Edison Awards Apr 24 2017 
Quest Diagnostics 50th Anniversary: Celebrating a Half Century of Life-Changing Results Apr 24 2017 
Quest Diagnostics To Release First Quarter 2017 Financial Results On April 20 Apr 07 2017 
Quest Diagnostics Presents Supplier Excellence Awards to Five Partners Apr 06 2017 

More From Other Websites
3 Top Dividend Stocks in Gene Sequencing May 24 2017
Quest Diagnostics (DGX) Up 1.8% Since Earnings Report: Can It Continue? May 23 2017
Quest Diagnostics Poised on Solid Q1 Results Despite Woes May 22 2017
These states have the most workers using illegal drugs May 17 2017
[$$] More American Workers Are Testing Positive for Drugs May 16 2017
Quest Diagnostics Declares Quarterly Cash Dividend May 16 2017
Increases in Illicit Drugs, Including Cocaine, Drive Workforce Drug Positivity to Highest Rate in 12... May 16 2017
Quest Diagnostics To Speak At The UBS Global Healthcare Conference May 12 2017
CSAIL 2016-C6 Commercial Mortgage Trust -- Moody's Affirms Eight Classes of CSAIL 2016-C6 May 04 2017
Quest Diagnostics To Speak At The Deutsche Bank 42nd Annual Health Care Conference May 02 2017
Quest Diagnostics and PeaceHealth Complete Transaction to Increase Access to Innovative, High-value... May 01 2017
Quest Diagnostics CIO Lidia Fonseca Wins 2017 Forbes CIO Innovation Award May 01 2017
Quest Diagnostics CIO Harnesses Insights And Technology For Better Healthcare Results May 01 2017
J.P. Morgan Chase Commercial Mortgage Securities Corp. 2004-C3 -- Moody's Affirms Four Classes of... Apr 27 2017
Chipotle Downgraded; McDonald's Gets Price Hikes; Snap Started At Hold Apr 26 2017
Quest Diagnostics’ Multi-Pronged Strategy to Accelerate Growth Apr 26 2017
Quest Diagnostics Is Targeting 3 Focus Areas to Accelerate Growth Apr 26 2017
Quest Diagnostics Is Making Steady Progress in 5-Point Strategy Apr 26 2017
ETFs with exposure to Quest Diagnostics, Inc. : April 25, 2017 Apr 25 2017
Quest Diagnostics Projects Run Rate Savings by End of 2017 Apr 25 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}